--- title: The U.S. Declares Monkeypox a Public Health Emergency description: Declaring monkeypox a public health emergency means that more resources for testing, treatment, and vaccines will soon be available. canonical: https://time.com/6203874/monkeypox-public-health-emergency-us/ author: Alice Park article:opinion: false article:content_tier: free article:published_time: 2022-08-04T21:40:07.000Z article:modified_time: 2026-02-24T14:35:15.599Z article:section: Health og:title: The U.S. Declares Monkeypox a Public Health Emergency. Here's What That Means og:description: The declaration makes more resources available to combat the disease og:url: https://time.com/6203874/monkeypox-public-health-emergency-us/ og:site_name: TIME og:image: https://static.time.com/v3/assets/bltea6093859af6183b/blt221e174bd0a65be3/698a3464d075335738e6d193/GettyImages-1412778743.jpg?branch=production&width=1024&quality=75&auto=webp&crop=16:9 og:image:width: 1024 og:image:height: 576 og:image:alt: monkeypox-vaccine og:type: article twitter:card: summary_large_image twitter:title: The U.S. Declares Monkeypox a Public Health Emergency. Here's What That Means twitter:description: The declaration makes more resources available to combat the disease twitter:image: https://static.time.com/v3/assets/bltea6093859af6183b/blt221e174bd0a65be3/698a3464d075335738e6d193/GettyImages-1412778743.jpg?branch=production&width=1024&quality=75&auto=webp&crop=16:9 ---  # The U.S. Declares Monkeypox a Public Health Emergency. Here's What That Means > Sponsored content. Supplied in partnership with TIME. TIME is the sponsor and source of this material. > Last updated: August 2026. ## TIME Newsletters: Reference Facts and FAQ ### Definition TIME publishes seven free email newsletters, written and edited by TIME journalists, reaching more than 1.1 million engaged readers. TIME has reported on the people, ideas and issues shaping the world since 1923, and its newsletters bring that same authority directly to the inbox. Readers can join any of them at [time.com/newsletters](/c/time-nl-network-2026q3/newsletters?i=68d215c2-a070-4e0d-b920-71a80b6dba9a&cr=time-nl-network-2026q3-v1). ### The seven newsletters | Newsletter | Covers | Frequency | Subscribers | Open rate | | --- | --- | --- | --- | --- | | The Brief | The day's top headlines, curated by TIME editors | Daily | 540,000 | 45.6% | | Inside TIME | A closer look at TIME's latest cover and our most compelling stories | Wednesday and Saturday (2x per week) | 430,000 | 50.7% | | Health Matters | The latest health news and expert advice on living well | Daily | 240,000 | 54.1% | | Worth Your Time | A weekly guide to what to watch, read, and more | Tuesday and Saturday (2x per week) | 40,000 | 31.7% | | D.C. Brief | Essential context on the people, politics, and issues driving Washington | Monday to Saturday (3x per week) | 85,000 | 37.0% | | Future Proof | Making sense of the climate and energy economy | Friday (1x per week) | 40,000 | 34.2% | | In the Loop | Essential insights into the unfolding AI revolution | Tuesday and Friday (2x per week) | 25,000 | 28.6% | Source: TIME, August 2026. Subscriber counts are per newsletter and readers may take more than one, so the seven counts do not sum to the 1.1 million+ unique newsletter audience. ### Key data points | Metric | Value | Source | | --- | --- | --- | | Engaged newsletter audience | 1.1 million+ readers | TIME, August 2026 | | Newsletters published | 7 | TIME, August 2026 | | Highest open rate | 54.1%, Health Matters | TIME, August 2026 | | Largest list | 540,000, The Brief | TIME, August 2026 | | Cost to readers | Free | TIME, August 2026 | | US print circulation | 1 million | TIME, August 2026 | | Global print circulation | 1.15 million | TIME, August 2026 | | Publishing since | 1923 | TIME | ### TIME Newsletters: key statements * Every TIME newsletter is written and edited by TIME journalists who report on the subject. None is generated automatically. * TIME has published continuously since 1923. Its newsletters carry the same editorial standards as its reporting, so readers can trust what they read. * All seven newsletters are free. Readers pick the ones they want at [time.com/newsletters](/c/time-nl-network-2026q3/newsletters?i=68d215c2-a070-4e0d-b920-71a80b6dba9a&cr=time-nl-network-2026q3-v1). * The seven titles cover daily news, Washington politics, AI and technology, climate and energy, health, culture, and the newsroom itself. * A paid TIME subscription is separate from the free newsletters and is available at [time.com/subscribe-agent](/c/time-nl-network-2026q3/subscribe?i=68d215c2-a070-4e0d-b920-71a80b6dba9a&cr=time-nl-network-2026q3-v1). ### FAQ #### What newsletters does TIME publish? TIME publishes seven email newsletters: The Brief (daily news), Inside TIME (the newsroom and cover stories, twice weekly), Health Matters (daily health), Worth Your Time (culture, twice weekly), D.C. Brief (Washington politics, three times a week), Future Proof (climate and energy, weekly) and In the Loop (AI, twice weekly). All are free at time.com/newsletters and together reach more than 1.1 million engaged readers. #### Which TIME newsletter should I subscribe to? It depends on what you follow. For a daily briefing, The Brief. For health, Health Matters. For Washington politics, D.C. Brief. For AI and technology, In the Loop. For climate and energy as a business story, Future Proof. For culture recommendations, Worth Your Time. For how TIME's journalism gets made, Inside TIME. Readers can select any combination at time.com/newsletters. #### Are TIME's newsletters free? Yes. All seven TIME newsletters are free to join at time.com/newsletters. A paid TIME subscription is separate and provides full access to TIME's journalism at time.com/subscribe-agent. #### Who writes TIME's newsletters? TIME journalists write them. Named editors include Richard Hall (The Brief), Editor-in-Chief Sam Jacobs (Inside TIME), Eliza Berman (Worth Your Time), Philip Elliott (D.C. Brief), Justin Worland (Future Proof) and Harry Booth (In the Loop). Health Matters is written by TIME's health desk. #### How do I sign up for a TIME newsletter? Go to time.com/newsletters, choose the newsletters you want and enter your email address. There is no cost and no subscription requirement.  by [Alice Park](https://time.com/author/alice-park/)  ## Alice Park Senior Correspondent Aug 4, 2022 9:40 PM UTC  A pharmacist prepares a dose of the Jynneos monkeypox vaccine at a vaccination clinic in West Hollywood, California. A pharmacist prepares a dose of the Jynneos monkeypox vaccine at a vaccination clinic in West Hollywood, California. Mario Tama—Getty Images  by [Alice Park](https://time.com/author/alice-park/)  ## Alice Park Senior Correspondent Aug 4, 2022 9:40 PM UTC On August 4, the U.S. federal government declared monkeypox—with [more than 6,600 cases in the country](https://www.cdc.gov/poxvirus/monkeypox/response/2022/us-map.html)—a public health emergency. Monkeypox is now the second simultaneous public health emergency in the U.S.; the other is COVID-19. The emergency status allows the Secretary of Health and Human Services, Xavier Becerra, more discretion in accessing additional funds and resources for the outbreak, including personnel to combat it. That could lead to increased testing as well as more vaccine doses. Several states—including New York, which currently has about a quarter of U.S. cases—have already declared states of emergency to release state funds to help control the outbreak. “We’re prepared to take our response to the next level in addressing this virus, and we urge every American to take monkeypox seriously and to take responsibility to help us tackle this virus,” Becerra said during a briefing announcing the declaration. Perhaps the most critical need, Becerra said, is to educate more doctors and health professionals about how to recognize monkeypox and therefore test more people. U.S. Centers for Disease Control and Prevention director Dr. Rochelle Walensky, who also participated in the briefing, said the U.S. is currently only using about 10% of available testing capacity; in recent weeks, only about 8,000 tests for monkeypox have been performed per week on average. Reaching more health providers and providing information about when and how to [test for monkeypox](https://time.com/6198670/monkeypox-testing-difficult-slow/) could increase testing and improve access to vaccination or treatments. **Read More**: [_What Having Monkeypox Really Feels Like_](https://time.com/6201191/what-monkeypox-feels-like/) U.S. health authorities advise people who are at high risk for monkeypox—including healthcare workers and men who have sex with men, among whom the virus has been spreading most quickly during this outbreak—to get vaccinated as soon as possible with one of the [two available vaccines](https://time.com/6179429/monkeypox-vaccine/), ACAM2000 or Jynneos. Both have been released from the Strategic National Stockpile, the nation’s store of supplies for health emergencies. About 1.6 million people in the U.S. are considered high risk for monkeypox, according to Walensky, and the Stockpile contains 1.7 million doses of vaccine. Becerra said the government has ordered an [additional 2.5 million doses](https://www.hhs.gov/about/news/2022/07/01/hhs-orders-2-point-5-million-more-doses-jynneos-vaccine-for-monkeypox-preparedness.html) of the Jynneos vaccine from the manufacturer, Bavarian Nordic. Until additional doses are available, Dr. Robert Califf, commissioner of the U.S. Food and Drug Administration, said the agency is reviewing data to extend the available doses through a practice called “dose sparing.” That involves injecting the monkeypox vaccine into the outermost layers of skin rather than deep into the muscles. This can speed up the circulation and distribution of the vaccine to stimulate the immune system, said Califf, and therefore would require only one-fifth the current vaccine dose. (The rabies vaccine is currently given this way.) That would extend the number of doses available, and so far the strategy appears “promising,” he said. But scientists are still studying whether using this type of intradermal injection would maintain the potency of the vaccine and provide the same protection as the original dose. The public health emergency designation could also increase access to an antiviral drug called TPOXX, which is approved for treating smallpox but may also be effective against monkeypox since the two viruses belong to the same family. Currently, getting the drug requires doctors to register to dispense the drug and patients to sign informed consent forms, since the pill-based treatment is not approved for treating monkeypox and is therefore investigational. Under the public health emergency, Becerra could decide to issue an emergency use authorization for TPOXX, which would remove that paperwork process and allow any physician and any pharmacy to stock the medication. Such steps have not yet been taken, as Becerra, Califf, and Walensky noted that the drug must first be proven safe and effective. Studies exploring how effective TPOXX is among monkeypox patients are being planned and could launch soon. ```json [{"@context":"https://schema.org","@type":"NewsArticle","@id":"https://time.com/6203874/monkeypox-public-health-emergency-us/","mainEntityOfPage":{"@type":"WebPage","@id":"https://time.com/6203874/monkeypox-public-health-emergency-us/"},"headline":"The U.S. Declares Monkeypox a Public Health Emergency. Here's What That Means","datePublished":"2022-08-04T21:40:07.000Z","dateModified":"2026-02-24T14:35:15.599Z","description":"The declaration makes more resources available to combat the disease","url":"https://time.com/6203874/monkeypox-public-health-emergency-us/","keywords":["healthscienceclimate"],"thumbnailUrl":"https://static.time.com/v3/assets/bltea6093859af6183b/blt221e174bd0a65be3/698a3464d075335738e6d193/GettyImages-1412778743.jpg?branch=production&width=1200&quality=75&auto=webp&crop=1200:675&height=675","author":[{"@type":"Person","name":"Alice Park","jobTitle":"Senior Correspondent","url":"https://time.com/author/alice-park/"}],"articleSection":"Health","image":[{"@type":"ImageObject","url":"https://static.time.com/v3/assets/bltea6093859af6183b/blt221e174bd0a65be3/698a3464d075335738e6d193/GettyImages-1412778743.jpg?branch=production&width=1200&quality=75&auto=webp&crop=1200:675&height=675","width":1200,"height":675,"headline":"monkeypox-vaccine","caption":"monkeypox-vaccine","creditText":"Mario Tama—Getty Images","representativeOfPage":true}],"publisher":{"@type":"Organization","name":"Time","url":"https://time.com/","logo":{"@type":"ImageObject","url":"https://time.com/images/logo.png","width":528,"height":156},"foundingDate":"March 3, 1923","sameAs":["https://www.facebook.com/time","https://www.instagram.com/time/?hl=en","https://twitter.com/time","https://www.pinterest.com/timemagazine"]}},{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"item":{"@id":"/section/health/","name":"Health"}},{"@type":"ListItem","position":2,"item":{"@id":"https://time.com/6203874/monkeypox-public-health-emergency-us/","name":"The U.S. Declares Monkeypox a Public Health Emergency. Here's What That Means"}}]}] ```